These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 8423958

  • 1. The prevalence of substance abuse among pregnant women in Utah.
    Buchi KF, Varner MW, Chase RA.
    Obstet Gynecol; 1993 Feb; 81(2):239-42. PubMed ID: 8423958
    [Abstract] [Full Text] [Related]

  • 2. Community-wide estimation of illicit drug use in delivering women: prevalence, demographics, and associated risk factors.
    Vaughn AJ, Carzoli RP, Sanchez-Ramos L, Murphy S, Khan N, Chiu T.
    Obstet Gynecol; 1993 Jul; 82(1):92-6. PubMed ID: 8515933
    [Abstract] [Full Text] [Related]

  • 3. Prenatal substance use in a Western urban community.
    Buchi KF, Varner MW.
    West J Med; 1994 Nov; 161(5):483-6. PubMed ID: 7810126
    [Abstract] [Full Text] [Related]

  • 4. Substance abuse during pregnancy in a rural population.
    Sloan LB, Gay JW, Snyder SW, Bales WR.
    Obstet Gynecol; 1992 Feb; 79(2):245-8. PubMed ID: 1731293
    [Abstract] [Full Text] [Related]

  • 5. Substance use in an inner-city family planning population.
    Harwell TS, Spence MR, Sands A, Iguchi MY.
    J Reprod Med; 1996 Sep; 41(9):704-10. PubMed ID: 8887198
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Universal screening for substance abuse at the time of parturition.
    Azadi A, Dildy GA.
    Am J Obstet Gynecol; 2008 May; 198(5):e30-2. PubMed ID: 18279831
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prevalence and magnitude of perinatal substance exposures in California.
    Vega WA, Kolody B, Hwang J, Noble A.
    N Engl J Med; 1993 Sep 16; 329(12):850-4. PubMed ID: 8355744
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cocaine use during pregnancy: prevalence and correlates.
    Frank DA, Zuckerman BS, Amaro H, Aboagye K, Bauchner H, Cabral H, Fried L, Hingson R, Kayne H, Levenson SM.
    Pediatrics; 1988 Dec 16; 82(6):888-95. PubMed ID: 3186380
    [Abstract] [Full Text] [Related]

  • 15. Anonymous cocaine screening in a private obstetric population.
    Burke MS, Roth D.
    Obstet Gynecol; 1993 Mar 16; 81(3):354-6. PubMed ID: 8437785
    [Abstract] [Full Text] [Related]

  • 16. Prevalence study of substance abuse in a midwestern city.
    Ware S, Liguori R, Jamerson P, Weiner V, Joubert-Jackson C.
    J Pediatr Nurs; 1993 Jun 16; 8(3):152-8. PubMed ID: 8340880
    [Abstract] [Full Text] [Related]

  • 17. Obstetric and perinatal outcomes in pregnancies associated with illicit substance abuse.
    Ludlow JP, Evans SF, Hulse G.
    Aust N Z J Obstet Gynaecol; 2004 Aug 16; 44(4):302-6. PubMed ID: 15282000
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Perinatal screening for drugs of abuse: reassessment of current practice in a high-risk area.
    Schulman M, Morel M, Karmen A, Chazotte C.
    Am J Perinatol; 1993 Sep 16; 10(5):374-7. PubMed ID: 8240597
    [Abstract] [Full Text] [Related]

  • 20. Substance abuse in pregnancy.
    Feng T.
    Curr Opin Obstet Gynecol; 1993 Feb 16; 5(1):16-23. PubMed ID: 8425031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.